171 related articles for article (PubMed ID: 28961947)
21. Comparative ability of various detergents to extract proteins of Borrelia burgdorferi and Borrelia hermsii.
Sambri V; Cevenini R
Microbiologica; 1991 Oct; 14(4):307-13. PubMed ID: 1723136
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of detergents on keratinocyte gene expression.
van Ruissen F; Le M; Carroll JM; van der Valk PG; Schalkwijk J
J Invest Dermatol; 1998 Apr; 110(4):358-63. PubMed ID: 9540975
[TBL] [Abstract][Full Text] [Related]
23. Comparison of detergent-based decellularization protocols for the removal of antigenic cellular components in porcine aortic valve.
Liu X; Li N; Gong D; Xia C; Xu Z
Xenotransplantation; 2018 Mar; 25(2):e12380. PubMed ID: 29446183
[TBL] [Abstract][Full Text] [Related]
24. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
25. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a Triton X-100 replacement for virus inactivation.
Luo W; Hickman D; Keykhosravani M; Wilson J; Fink J; Huang L; Chen D; O'Donnell S
Biotechnol Prog; 2020 Nov; 36(6):e3036. PubMed ID: 32533632
[TBL] [Abstract][Full Text] [Related]
27. Insights into virus inactivation by polysorbate 80 in the absence of solvent.
Chen D; Luo W; Hoffman J; Huang L; Sandefur S; Hall T; Murphy M; O'Donnell S
Biotechnol Prog; 2020 May; 36(3):e2953. PubMed ID: 31846227
[TBL] [Abstract][Full Text] [Related]
28. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
29. Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform.
Cnops L; Van den Eede P; Pettitt J; Heyndrickx L; De Smet B; Coppens S; Andries I; Pattery T; Van Hove L; Meersseman G; Van Den Herrewegen S; Vergauwe N; Thijs R; Jahrling PB; Nauwelaers D; Ariën KK
J Infect Dis; 2016 Oct; 214(suppl 3):S192-S202. PubMed ID: 27247341
[TBL] [Abstract][Full Text] [Related]
30. Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC.
Farcet JB; Karbiener M; Zelger L; Kindermann J; Kreil TR
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175626
[TBL] [Abstract][Full Text] [Related]
31. The action of Triton X-100 and sodium dodecyl sulphate on lipid layers. Effect on monolayers and liposomes.
Hernández-Borrell J; Pons M; Juarez JC; Estelrich J
J Microencapsul; 1990; 7(2):255-9. PubMed ID: 2329450
[TBL] [Abstract][Full Text] [Related]
32. Effective Chemical Inactivation of Ebola Virus.
Haddock E; Feldmann F; Feldmann H
Emerg Infect Dis; 2016 Jul; 22(7):1292-4. PubMed ID: 27070504
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of human immunodeficiency virus in serum specimens as a safety measure for diagnostic immunoassays.
Ukkonen P; Korpela J; Suni J; Hedman K
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):518-23. PubMed ID: 3141160
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.
Qiu X; Audet J; Wong G; Pillet S; Bello A; Cabral T; Strong JE; Plummer F; Corbett CR; Alimonti JB; Kobinger GP
Sci Transl Med; 2012 Jun; 4(138):138ra81. PubMed ID: 22700957
[TBL] [Abstract][Full Text] [Related]
35. Validating the Inactivation Effectiveness of Chemicals on Ebola Virus.
Haddock E; Feldmann F
Methods Mol Biol; 2017; 1628():251-257. PubMed ID: 28573626
[TBL] [Abstract][Full Text] [Related]
36. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
[TBL] [Abstract][Full Text] [Related]
37. Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.
Reisler RB; Yu C; Donofrio MJ; Warren TK; Wells JB; Stuthman KS; Garza NL; Vantongeren SA; Donnelly GC; Kane CD; Kortepeter MG; Bavari S; Cardile AP
Emerg Infect Dis; 2017 Aug; 23(8):1316-1324. PubMed ID: 28726603
[TBL] [Abstract][Full Text] [Related]
38. Evaluation in nonhuman primates of vaccines against Ebola virus.
Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
[TBL] [Abstract][Full Text] [Related]
39. Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts.
Wang Y; Bao J; Wu Q; Zhou Y; Li Y; Wu X; Shi Y; Li L; Bu H
Xenotransplantation; 2015; 22(1):48-61. PubMed ID: 25291435
[TBL] [Abstract][Full Text] [Related]
40. On the size of pores arising in erythrocytes under the action of detergents.
Senkovich OA; Chernitsky EA
Membr Cell Biol; 1998; 11(5):679-89. PubMed ID: 9672884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
